There appears to be a concerted response of POMC, α-MSH, and β-endorphin in melanoma as the immunoreactivity of these peptides is higher and more diffuse in metastatic and advanced melanoma compared to benign melanocytic naevi, which confirms the involvement of the POMC gene and its derivated peptides [172]. This evidence concerns the gene STAMBP and melanoma.